Approved Glucose Monitor Does Not Meet Regulatory Standards, May Overestimate Hypoglycemic Values
The MyGlucoHealth blood glucose meter did not meet regulatory standards and may overestimate values in the hypoglycemic range.
Hypoglycemia
Wearable Device for Heart Rate Variability Can Detect Early Hypoglycemia
A wearable device that measures real-time heart rate variability can detect early signs of hypoglycemia in patients with type 1 diabetes.
Hypoglycemia Often Unrecognized by Older Adults With T1D
Blood sugar levels of older adults with type 1 diabetes are in the hypoglycemic range for more than an hour a day, and blood sugar levels of those with impaired hypoglycemia awareness may be in hypoglycemic range even longer.
Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
Professional and personal continuous glucose monitoring systems exhibit similar accuracy in both inpatient and home settings, with both having lower sensor performance during hypoglycemic episodes.
High Prevalence of Fasting-Evoked Hypoglycemia in Diabetes
About 17 percent of patients with diabetes report experiencing hypoglycemia when fasting for lab tests.
Hypoglycemia Following Antifungal Treatment in Patient With Type 1 Diabetes
“This is the first report of decreased insulin requirements in a patient with [T1D] correlating with micafungin administration,” noted the authors.
Ready-to-Use Glucagon Rescue Pen for Severe Hypoglycemia Under FDA Review
The NDA included findings from multiple Phase 3 trials evaluating the safety, efficacy, and utility of the Xeris glucagon rescue pen auto-injector to treat severe hypoglycemia vs currently available glucagon emergency kits in children, adolescents, and adults with type 1 diabetes.
Lorcaserin Facilitates Weight Loss in Patients Who Are Overweight, Obese
Lorcaserin facilitates sustained weight loss without increasing the rate of major cardiovascular events among overweight or obese patients.
Mini-Dose Glucagon Helps Prevent Exercise-Induced Hypoglycemia in T1D
Mini-dose glucagon was as effective as glucose tablets for preventing hypoglycemia and may result in less post intervention hyperglycemia.
Fewer Major Adverse Cardiovascular Events With New Antihyperglycemic Drugs With Lower Hypoglycemic Risk
Investigators proposed that reduction in MACE may be proportional to the magnitude of HbA1c reduction seen with newer antihyperglycemic agents.
-
Loading...
-
Loading...
Next post in Type 2 Diabetes
